Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 14/20 | 0.72 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.72 |
| ▸ | HDAC3 | O15379 | 8/20 | 0.72 |
| ▸ | MGLL | Q99685 | 3/20 | 0.63 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3790332 | 0.95 | HDAC1 (0.69) | HDAC1HDAC2HDAC3MGLLKCNH2 | |
| SCHEMBL3790375 | 0.92 | HDAC1 (0.67) | HDAC1HDAC2HDAC3MGLLKCNH2 | |
| SCHEMBL3793285 | 0.89 | MGLL (0.63) | HDAC1HDAC2HDAC3MGLLKCNH2 | |
| SCHEMBL3783894 | 0.88 | HDAC1 (0.68) | HDAC1HDAC2HDAC3MGLLKCNH2 | |
| SCHEMBL13833537 | 0.84 | HDAC1 (1.00) | HDAC1HDAC2HDAC3 | |
| SCHEMBL3790841 | 0.84 | HDAC1 (0.57) | HDAC1HDAC2HDAC3MGLLKCNH2 | |
| SCHEMBL8106177 | 0.83 | HDAC1 (1.00) | HDAC1HDAC2HDAC3KCNH2 | |
| SCHEMBL3811403 | 0.83 | NPC1 (0.68) | HDAC1HDAC2HDAC3MGLLNPC1 | |
| SCHEMBL3785606 | 0.82 | MGLL (0.57) | HDAC1HDAC2HDAC3MGLLENPP2 | |
| SCHEMBL3642625 | 0.80 | HDAC1 (0.75) | HDAC1HDAC2HDAC3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | HDAC1 1686/4885HDAC2 549/4885HDAC3 2675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.